LOVELAND, Colo., Dec. 30, 2014 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today Dr. Robert Grieve, Executive Chair, will present at The Sidoti Company, LLC's 2015 Emerging Growth Institutional Investor Forum on Monday, January 12, 2015. The company's group presentation is scheduled for 8 a.m. (ET) in Estate 3 and management will be available throughout the day for one-on-one meetings. Please email hska@haydenir.com or contact your Sidoti representative to schedule a one-on-one meeting.
For more information about The Sidoti Company, LLC's Emerging Growth Institutional Investor Forum, visit http://www.sidoti.com/events/default.aspx.
About Sidoti & Company, LLC
Sidoti & Company, LLC, founded in 1999, is Wall Street's preeminent provider of equity research focused on undiscovered, profitable companies at a market capitalization of less than $3 billion. Sidoti's coverage universe comprises nearly 500 companies across a range of industries. Sidoti's approach affords institutional investor clients an exclusive combination of high-quality research, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams and extensive trading support. Sidoti's experienced sales force and trading desk serve nearly 500 institutional clients in the U.S., Canada and the U.K., including many leading managers of portfolios with $200 million to $2 billion of assets. Sidoti's investor conferences are for the exclusive benefit of their clients.
About Heska
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include blood testing instruments and supplies, digital imaging products, software and services, and single use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.
At Heska Corporation: | At Hayden IR: |
Jason Napolitano, Executive Vice President & CFO | Brett Maas, Managing Partner |
970.493.7272, ext. 4105 | 646.536.7331 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heska-to-present-at-sidoti-emerging-growth-institutional-investor-forum-300014538.html
SOURCE Heska Corporation
